RecruitingNCT04097158

Biomarkers in Different Types of Amyotrophic Lateral Sclerosis (ALS) Patients Being Treated With Edaravone

Studying Amyotrophic lateral sclerosis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Loma Linda University
Principal Investigator
Jeffrey Rosenfeld, PhD, MD
Loma Linda University
Intervention
Sample Collection(other)
Enrollment
160 enrolled
Eligibility
18-85 years · All sexes
Timeline
20192026

Study locations (1)

Collaborators

Temple University · Thomas Jefferson University · University of Southern California · Northwestern University

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04097158 on ClinicalTrials.gov

Other trials for Amyotrophic lateral sclerosis

Additional recruiting or active studies for the same condition.

See all trials for Amyotrophic lateral sclerosis

← Back to all trials